Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenue | $ 1,511 | $ 1,057 | $ 4,343 | $ 1,755 | ||
| Operating expenses: | ||||||
| Cost of revenue (exclusive of depreciation and amortization below) | 128 | 60 | 240 | 110 | ||
| Research and development | 19,723 | 13,012 | 37,604 | 23,020 | ||
| General and administrative | 11,051 | 2,184 | 20,276 | 4,096 | ||
| Sales and marketing | 547 | 372 | 1,948 | 600 | ||
| Depreciation and amortization | 1,639 | 1,259 | 3,256 | 2,535 | ||
| Other operating income, net | (1,586) | (307) | (5,724) | (318) | ||
| Total operating expenses | 31,502 | 16,580 | 57,600 | 30,043 | ||
| Loss from operations | (29,991) | (15,523) | (53,257) | (28,288) | ||
| Other income (expense), net: | ||||||
| Interest income (expense), net | 2,319 | 342 | 2,129 | 894 | ||
| Loss on fair value of earn-out share liabilities, net | (10,597) | 0 | (7,764) | 0 | ||
| Loss on derivative instruments, net | (1,907) | 0 | (1,907) | 0 | ||
| Other income (expense), net | (1,875) | 41 | (1,856) | 49 | ||
| Total other income (expense), net | (12,060) | 383 | (9,398) | 943 | ||
| Net loss | $ (42,051) | $ (15,140) | $ (62,655) | $ (27,345) | ||
| Net loss per share, basic (in dollars per share) | [1] | $ (0.14) | $ (0.27) | $ (0.34) | $ (0.49) | |
| Net loss per share, diluted (in dollars per share) | [1] | $ (0.14) | $ (0.27) | $ (0.34) | $ (0.49) | |
| Weighted average shares outstanding, basic (in shares) | [1] | 299,964,510 | 55,786,865 | 186,551,397 | 55,718,926 | |
| Weighted average shares outstanding, diluted (in shares) | [1] | 299,964,510 | 55,786,865 | 186,551,397 | 55,718,926 | |
| Comprehensive loss: | ||||||
| Net loss | $ (42,051) | $ (15,140) | $ (62,655) | $ (27,345) | ||
| Cumulative translation adjustment | 454 | 916 | 237 | 979 | ||
| Net comprehensive loss | $ (41,597) | $ (14,224) | $ (62,418) | $ (26,366) | ||
| ||||||
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Earnout Share, Gain (Loss) on Liabilities, Net No definition available.
|